公司资料
Nemaura Medical 股价、新闻与催化剂
- 股票代码:
- NMRD
- 交易所:
- PINK
- 行业:
- Biopharma
- 所在地:
- United Kingdom and trades in the U
股票表现
0.00 USD (-99.00%)
收盘价
最后更新: 2026年8月4日
—
市值
股价为何变动
Current closing-price context is not available for NMRD.
公司概览
业务概览
Nemaura Medical is a healthcare technology company focused on noninvasive glucose monitoring and chronic-disease management tools. Its story is built around the promise of sensor-based monitoring without traditional finger-stick workflows.
所在地与行业分类
Nemaura Medical is headquartered in the United Kingdom and trades in the U.S. market. It sits in medical technology and digital health rather than biotech therapeutics.
商业模式特征
The business depends on product adoption, commercialization, and the ability to translate noninvasive monitoring into recurring usage. Investors focus on device rollout, reimbursement, and execution more than on drug-development catalysts.
生物医药行业定位
Nemaura sits in the chronic-care device and digital-monitoring layer of healthcare. It is not biotech proper, but it belongs to the broader health-tech stack where adoption and reimbursement matter most.
未来催化剂
- Nemaura Medical’s catalysts are diabetes-monitoring and metabolic-health products, plus any commercialization update that shows the platform can still gain traction. The company needs more visible adoption.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。